Rankings
▼
Calendar
LTRN FY 2019 Earnings — Lantern Pharma Inc. Revenue & Financial Results | Market Cap Arena
LTRN
Lantern Pharma Inc.
$30M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$1,627
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-0.39
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$117,760
Balance Sheet
Total Assets
$1M
Total Liabilities
$489,292
Stockholders' Equity
$943,284
Cash & Equivalents
$1M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$1,627
$2,544
-164.0%
Operating Income
-$2M
-$2M
-40.6%
Net Income
-$2M
-$2M
-40.6%
← FY 2018
All Quarters
Q1 2019 →